Syneos Health Inc - Ordinary Shares - Class A

NASDAQ:SYNH   10:29:01 AM EDT
73.95
-1.49 (-1.98%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)7.69B
Current PE40.06
Forward PE 21.75
2yr Forward PE 17.52
See more stats
Estimates Current Quarter
Revenue$1.14 Billion
Adjusted EPS$1.10
See more estimates
10-Day MA$75.25
50-Day MA$68.71
200-Day MA$60.59
See more pivots

Syneos Health, Inc. Stock, NASDAQ:SYNH

3201 BEECHLEAF COURT, SUITE 600, RALEIGH, NC 27604
United States of America
Phone: 919-876-9300
Number of Employees: 24000

Description

Syneos Health, Inc. operates as an integrated biopharmaceutical solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers various clinical development services spanning Phase I to Phase IV, including full-service global studies, as well as unbundled service offerings, such as clinical monitoring, investigator recruitment, patient recruitment, data management, and study startup to assist customers with drug development process. The Commercial Solutions segment provides commercialization services, including outsourced field selling solutions, medication adherence, communications, and consulting services. Its customers include small, mid-sized, and large companies in the pharmaceutical, biotechnology, and medical device industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Raleigh, North Carolina.